Collegium Pharmaceutical, Inc. COLL Change in fair value of contingent consideration
Change in fair value of contingent consideration at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s change in fair value of contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s change in fair value of contingent consideration?
- Collegium Pharmaceutical, Inc. (COLL) reported change in fair value of contingent consideration of $0 in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s change in fair value of contingent consideration changed year-over-year?
- Collegium Pharmaceutical, Inc.'s change in fair value of contingent consideration increased by 100.0% year-over-year, from -$786K to $0.
- What does change in fair value of contingent consideration mean?
- The non-cash adjustment to the fair value of liabilities related to acquisition-based contingent consideration, such as earn-outs. Changes in this value reflect updates to management's expectations regarding the probability and timing of future payments to sellers.